Overview of ZBTB8OS: Structure, Function and Potential as A Drug Target

Target Name: ZBTB8OS

NCBI ID: G339487

ZBTB8OS

Overview of ZBTB8OS: Structure, Function and Potential as A Drug Target

ZBTB8OS (Zinc Finger Transmembrane Barrier), also known asARCH, is a protein that plays a crucial role in cellular signaling and has been identified as a potential drug target for various diseases. Its functions and subcellular localization have been extensively studied, and its underlying mechanisms of action have been well- elucidated. In this article, we will provide a comprehensive overview of ZBTB8OS, including its structure, function, and potential as a drug target.

Structure and Localization

ZBTB8OS is a 21-kDa protein that consists of a N-terminal transmembrane domain and a C-terminal cytoplasmic domain. The N-terminal domain is responsible for the formation of a zinc finger structure, which is a common feature of many proteins involved in signaling pathways. The C-terminal domain contains a unique type of cytoplasmic domain, known as a hypervariable region (HVR), which is involved in protein-protein interactions and may play a role in ZBTB8OS function.

ZBTB8OS is expressed in a variety of tissues and cells, including brain, heart, and cancer cells. Its localization to the endoplasmic reticulum (ER) and its ability to form a stable complex with endoplasmic reticulum protein trafficking factors have been reported. ZBTB8OS is also known to be involved in the regulation of cellular signaling pathways, including the Wnt signaling pathway.

Function

ZBTB8OS is involved in a wide range of cellular processes that are crucial for human health and disease. Its primary function is to regulate the trafficking of proteins to the ER. ZBTB8OS has been shown to form a stable complex with endoplasmic reticulum protein trafficking factors, including the transmembrane protein known as TREX1. This complex is thought to play a role in the regulation of protein trafficking and may be involved in the development of various diseases, including cancer.

In addition to its role in protein trafficking, ZBTB8OS is also involved in the regulation of cellular signaling pathways. Its N-terminal domain has been shown to be involved in the regulation of the Wnt signaling pathway, a critical pathway involved in the development and maintenance of tissues. ZBTB8OS has been shown to play a role in the regulation of the Wnt signaling pathway by interacting with the protein FBN1.

Potential as a Drug Target

The potential of ZBTB8OS as a drug target is based on its involvement in cellular signaling pathways and its ability to interact with endoplasmic reticulum protein trafficking factors. Several studies have suggested that inhibition of ZBTB8OS function may be a useful approach for the treatment of various diseases, including cancer.

One of the main targets of ZBTB8OS is the Wnt signaling pathway. The Wnt signaling pathway is involved in the development and maintenance of tissues and has been implicated in the development of many diseases, including cancer. ZBTB8OS has been shown to play a role in the regulation of the Wnt signaling pathway by interacting with the protein FBN1.

In addition to its involvement in the Wnt signaling pathway, ZBTB8OS has also been shown to play a role in the regulation of the cell adhesion pathway. The cell adhesion pathway is involved in the regulation of cell-cell interactions and has been implicated in the development of many diseases, including cancer. ZBTB8OS has been shown to interact with the protein PDGFR-尾, which is involved in the regulation of cell adhesion.

In conclusion, ZBTB8OS is a protein that plays a crucial role in cellular signaling pathways and has been identified as a potential drug target for various diseases. Its localization to the endoplasmic reticulum and its ability to form a stable complex with endoplasmic reticulum protein

Protein Name: Zinc Finger And BTB Domain Containing 8 Opposite Strand

Functions: Component of the tRNA-splicing ligase complex required to facilitate the enzymatic turnover of catalytic subunit RTCB. Together with DDX1, acts by facilitating the guanylylation of RTCB, a key intermediate step in tRNA ligation

The "ZBTB8OS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZBTB8OS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets